Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Unknown 25Completed 25Recruiting 22Not yet recruiting 15Terminated 6Active not recruiting 3Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 989Neoplasms 848Carcinoma, Non-Small-Cell Lung 842Prostatic Neoplasms 527Neoplasm Metastasis 500Leukemia, Myeloid, Acute 488Melanoma 453Colorectal Neoplasms 446Multiple Myeloma 440Lung Neoplasms 419Pancreatic Neoplasms 352Recurrence 350Lymphoma 349Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 327Leukemia 323Leukemia, Lymphocytic, Chronic, B-Cell 301Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 243Carcinoma, Hepatocellular 234Squamous Cell Carcinoma of Head and Neck 231Glioblastoma 231Myelodysplastic Syndromes 229Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

Letrozole 2Goserelin 2Fulvestrant 2olaparib 1abemaciclib 1Trastuzumab 1Lead 1Aromatase Inhibitors 1Anastrozole 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Interventional × Advanced Breast Cancer × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

NCT04227327 2025-07-29

HERMIONE-7

University of Milano Bicocca

Phase 2 Terminated
31 enrolled
Breast

Advanced Breast Cancer

NCT04862143 2024-06-20

TELEPIK

Novartis

Phase 2 Terminated
2 enrolled 10 charts
Breast

Advanced Breast Cancer

NCT04714619 2023-12-19

CAILA

MedSIR

Phase 2 Terminated
2 enrolled
Breast

Advanced Breast Cancer

NCT03931551 2023-02-22

OPHELIA

MedSIR

Phase 2 Terminated
5 enrolled
Breast

Advanced Breast Cancer

NCT02054338 2019-08-28

VICTORIA

Pierre Fabre Medicament

Phase 3 Terminated
1,004 enrolled 11 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡